Use of 7Alpha-hydroxy-estradiol, 7Alpha-hydroxy-dehydroepiandrosteron e and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration

Details for Australian Patent Application No. 2001233856 (hide)

Owner Hunter-Fleming Limited University of Edinburgh BTG International Limited

Inventors Seckl, Jonathan Robert; Martin, Keith Frank; Lathe, Richard Frank; Wulfert, Ernst Arne

Agent Watermark

Pub. Number AU-B-2001233856

PCT Pub. Number WO01/60375

Priority 0003524 15.02.00 GB

Filing date 15 February 2001

Wipo publication date 27 August 2001

Acceptance publication date 25 May 2006

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Event Publications

25 May 2006 Application Accepted

  Published as AU-B-2001233856

1 June 2006 Assignment before Grant

  University of Edinburgh; BTG International Limited; Hunter-Fleming Limited The application has been assigned to University of Edinburgh

21 September 2006 Standard Patent Sealed

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001233857

2001233851